SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11501170
Source:
http://linkedlifedata.com/resource/pubmed/id/11501170
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0118168
,
umls-concept:C0216784
,
umls-concept:C1280500
,
umls-concept:C1383860
pubmed:issue
9
pubmed:dateCreated
2001-8-14
pubmed:abstractText
To study the influence of angiotensin (Ang) II receptor antagonist (AT1) valsartan and angiotensin-converting enzyme (ACE) inhibitor fosinopril on the cardiac hypertrophy induced by catecholamine.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100956087
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Transporting ATPases
,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen
,
http://linkedlifedata.com/resource/pubmed/chemical/Fosinopril
,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine
,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Potassium-Exchanging ATPase
,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Valine
,
http://linkedlifedata.com/resource/pubmed/chemical/valsartan
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1671-4083
pubmed:author
pubmed-author:HuangJJ
,
pubmed-author:XiangYY
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
850-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11501170-Angiotensin Receptor Antagonists
,
pubmed-meshheading:11501170-Angiotensin-Converting Enzyme Inhibitors
,
pubmed-meshheading:11501170-Animals
,
pubmed-meshheading:11501170-Apoptosis
,
pubmed-meshheading:11501170-Calcium-Transporting ATPases
,
pubmed-meshheading:11501170-Collagen
,
pubmed-meshheading:11501170-Female
,
pubmed-meshheading:11501170-Fosinopril
,
pubmed-meshheading:11501170-Hypertrophy, Left Ventricular
,
pubmed-meshheading:11501170-Male
,
pubmed-meshheading:11501170-Myocardium
,
pubmed-meshheading:11501170-Norepinephrine
,
pubmed-meshheading:11501170-Rats
,
pubmed-meshheading:11501170-Rats, Sprague-Dawley
,
pubmed-meshheading:11501170-Sodium-Potassium-Exchanging ATPase
,
pubmed-meshheading:11501170-Tetrazoles
,
pubmed-meshheading:11501170-Valine
,
pubmed-meshheading:11501170-Ventricular Remodeling
pubmed:year
2000
pubmed:articleTitle
Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy.
pubmed:affiliation
Department of Cardiology, Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
pubmed:publicationType
Journal Article